71% achieved a >30% reduction in UP/Cr, a key indicator of kidney damage. 71% demonstrated improved or stabilized eGFR, signaling preserved kidney function. 37.5% had increased urinary VEGF ...

Six-month open-label study showed clinically meaningful improvements in kidney function and disease in patients with Type 2 diabetic nephropathy. 71% achieved a >30% reduction in UP/Cr, a key ...

36% had reduced urinary synaptopodin losses, indicating healthier kidney cells and structure. "The positive results from our Phase 2b study evaluating a melanocortin agonist in patients with diabetic ...

1:49 Sales of N.B. lip balm company up 90% amid ‘buy Canadian’ movement A Moncton-based lip balm company says sales are up by almost 90 per cent because of the “Buy Canadian” movement ...

The ongoing Phase 1 clinical trial is a multi-center ... trial results may not match results observed to date, may be negative or ambiguous, or may not reach the level of statistical significance ...

PORT ORFORD, Oregon – The Oregon Department of Transportation is about to begin work on the second phase of the Arizona landslide project on Highway 101 on the southern Oregon coast. In January 2023, ...

Shares of Cartesian Therapeutics climbed after the company announced positive results in a phase 2b trial of its lead cell-therapy candidate. The stock was up 8.3% to $15.60 in morning trading ...

“The remarkable results from Cohort 3 of the ongoing Phase 2 trial reinforce the potential of SLS009 to transform outcomes for these heavily pretreated AML patients,” said Angelos Stergiou, MD, ScD ...

“The remarkable results from Cohort 3 of the ongoing Phase 2 trial reinforce the potential of SLS009 to transform outcomes for these heavily pretreated AML patients,” said Angelos ...

The randomized, double-blind, placebo-controlled Phase 1 single/multiple ascending dose (SAD/MAD) study evaluated the safety, tolerability and pharmacokinetics of oral CVN293 in 72 healthy adult ...